Andrea Olariu, MD, PhD is Chief Executive Officer (CEO) of Medicines360. Since joining the company in 2010, Dr. Olariu has held several key roles for the organization. During her time as Chief Operations Officer (COO), Dr. Olariu oversaw Clinical/Medical and Regulatory Affairs, Product Development, and the Quality Department. Prior to her appointment as CEO for Medicines360, Dr. Olariu served as CEO for CuraePharma360.
In her steady tenure at Medicines360, Dr. Olariu led the development, approval and product expansion strategy for the company’s hormonal IUD. Dr. Olariu has extensive experience designing and conducting clinical trials from proof-of-concept to large pivotal Phase 3 studies.
Before joining Medicines360, Dr. Olariu developed and implemented clinical/medical and regulatory strategies for several medical devices that received approval in the United States, Canada, and the European Union. Prior to moving to the US, Dr. Olariu spent over 15 years working in academia, as an Associate Professor of Dermatology at the University of Szeged in Szeged, Hungary and as a Senior Lecturer of Immunology at the Victor Babes University of Medicine and Pharmacy Timisoara, Romania.
Dr. Olariu has authored over 40 peer-reviewed medical publications, is the recipient of several academic honors, and has spoken at national and international conferences.